Basiliximab is a glycoprotein monoclonal antibody that is produced by recombination technology. It is a chimeric monoclonal antibody, as it is produced from mouse and human cells. Basiliximab is used to prevent rejection of organ transplants (Kapic, 2004). Organ… Continue Reading →